Becton, Dickinson and Company (BDX)

263.40
5.99 2.33
NYSE
Prev Close 257.41
Open 257.04
Day Low/High 256.78 / 263.80
52 Wk Low/High 197.75 / 286.72
Volume 1.26M
Exchange NYSE
Shares Outstanding 283.48B
Market Cap 72.96B
P/E Ratio 76.60
Div & Yield N.A. (N.A)
The Next Deals Are in Hospital

The Next Deals Are in Hospital

A wave of M&A in the health sector makes sense.

Gems Hiding in the Shadows

Gems Hiding in the Shadows

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.

Boston Scientific upgraded at Piper

Becton Dickinson upgraded at Piper

Going for a Bounce-to-Base Transition

Going for a Bounce-to-Base Transition

Three charts forming around their 50-day moving average.

Defensive Stocks Ringing a False Alarm

Defensive Stocks Ringing a False Alarm

Outperformance by safe sectors often signals trouble, but not always.

P&G, Intel Offer More Than Dividends

P&G, Intel Offer More Than Dividends

Intel, P&G and Becton Dickinson offer more than steady dividend payments, Erich Patten, Cutler Equity Fund portfolio manager, tells Gregg Greenberg.

BDX Investor Mtg.

Stocks Under $5: Stealth Health Care Play

Stocks Under $5: Stealth Health Care Play

Portfolio Mgr. David Peltier uncovers a low-dollar healthcare stock with big growth potential.

Grab Some for the Next Leg Up

Grab Some for the Next Leg Up

This high-quality name seems ready for another sizable climb.

Becton Dickinson downgraded at Leerink

Brimming With Positives -- and Cheap

Brimming With Positives -- and Cheap

Becton Dickinson's P/E ratio is far below the 10-year median, and its payout has become quite generous.

A Pattern Shift in BDX

A Pattern Shift in BDX

At least three Fibonacci time cycles support a bullish stance against this recent low.

TJX, Microsoft Still Super Values

TJX, Microsoft Still Super Values

In this episode of Buy This, Sell That!, Robert McIver, portfolio manager for the Jensen Quality Value Fund, names his favorite stocks including Microsoft, Sysco and TJX.

Scalpal-Sharp Performance

Scalpal-Sharp Performance

This surgical-products name has proven itself recession-resistant, and stands to make you money.

The Day Ahead: Various Events on Tap

The Day Ahead: Various Events on Tap

Traders awaited Greek debt-related news, testimony from Bernanke and some high-profile earnings reports.

Technicals Bode Well for Arris, Becton

Technicals Bode Well for Arris, Becton

Both charts are displaying one of my favorite technical conditions.

The Day Ahead: Awaiting Bernanke's Speech

The Fed chief is set to deliver his comments about the economic outlook this afternoon.